Match Day 2024: Entering Specialties With Great Need

Fourth-year MD Icahn School of Medicine students receiving their placements on Match Day, Friday, March 15, from left to right: Amina Avril, Claire Ufongene, Candida Damian, Yhan Colón Ibán, and Charlotte Pierce.

Match Day represents a milestone for fourth-year medical students across the country—it’s when they receive their placements for the residency programs they’ve applied to. On Friday, March 15, the Icahn School of Medicine at Mount Sinai’s Class of 2024 congregated at the Guggenheim Pavilion for Match Day, and 133 students matched to 26 different specialties across the nation.

Michael Leitman, MD, Professor of Surgery, and Medical Education, at Icahn Mount Sinai, and Dean for Graduate Medical Education, observes Match Day closely because it reflects the physician pipeline. In several critical areas, he says, most notably the primary care specialties (internal medicine, general pediatrics, family medicine, and geriatrics) and psychiatry, the supply of new doctors entering these specialties is barely sufficient to meet demand.

“These are areas where we are seeing low match rates among students, and we suspect that students are gravitating towards careers in more lucrative specialties in part because they’re concerned about debt,” says Dr. Leitman.

According to the National Resident Matching Program, the organization conducting the Main Residency Match, for the Class of 2024 MD seniors, 87.8 percent of family medicine residency positions were filled, compared to most other programs, which were filled 100 percent—or close to. Pediatrics and psychiatry programs had unfilled positions in this year’s match too.

A 2021 report from the Association of American Medical Colleges (AAMC) forecasts a primary care physician shortage of 18,000 to 48,000 in 2034. The big problem this shortage creates is that primary care is where important screenings are done, such as hypertension.

Positions filled in specialties with high need: 2024 vs 2023

Specialty 2024 2023
Family Medicine 87.8% 88.7%
Pediatrics 91.8% 97.1%
Psychiatry 99.5% 99.0%

“In the areas that we serve at The Mount Sinai Hospital, which includes East Harlem, we have to think about the loss of family medicine doctors who will not be available to care for this population, which will only further reinforce the health care disparities we are working so hard to correct,” says Dr. Leitman.

“Although historically, students from Icahn Mount Sinai have matched to primary care fields at lower rates than other specialties, this year’s Match represented the highest number of students matching into primary care specialties,” says Tara K Cunningham, EdD, MS, Senior Associate Dean for Student Affairs and Associate Professor of Medical Education, who leads the team responsible for career and residency advising at Icahn Mount Sinai. Last year, Dr. Cunningham says, two students entered pediatrics. “This year, a record-breaking 11 students are going into pediatrics.”

Icahn Mount Sinai’s Class of 2024 has more students placing into primary care and neurology than any other graduating class in school history. The most popular specialties for the class are internal medicine (28), pediatrics (11), anesthesiology (10), obstetrics (8), gynecology (8), neurology (7), ophthalmology (7), and psychiatry (7).

Two MD seniors entering residency programs in specialties with high need share their thoughts on their matches and what they hope to achieve in their respective fields.

Stephanie Ureña, Family Medicine program at NewYork-Presbyterian/Columbia University Irving Medical Center

What are your thoughts on your match, and tell me about the programs you applied for?

I am very happy with my result because this was my top choice. I wanted to stay in New York City and work with an underserved, majority-Hispanic population. I mostly applied to programs in New York City and Philadelphia because these are both places where I had a community. I was born and raised in the Bronx and this is where most of my immediate family is. I went to school at the University of Pennsylvania so I also had some friends there and some family that had also moved there.

What do you know about the challenges of the specialty you’re entering, and how do you think you might be able to overcome them?

I am going into family medicine and given the current medical system, there is never enough time for visits. Additionally, patients’ health is connected to social determinants of health and there are often not enough resources to keep patients healthy.

I plan on learning to prioritize pressing health issues for quick visits given the time crunch. I also plan on immersing myself into the community that I practice in so that I can learn about community resources that address some of their social determinants of health.

What inspired you to go into medicine in the first place?

I had a really awesome pediatrician growing up who was my constant cheerleader. I remember looking forward to his visits because he just wanted to catch up on life and would always teach me ways to stay healthy. Then as I grew up, I realized how much I liked science and was fascinated by the human body so I decided to continue to pursue a path in medicine.

What impact do you hope to achieve in your specialty?

For family medicine, I hope to continue to provide patient-centered health care and expand on my knowledge of community resources. I would ideally like to have a system in which I refer my patients to community resources that address their social determinants of health. I would also like to create more pipeline programs that bring students from the local community into medical schools that are in their community. I envision myself joining a community board and advocating for the community needs.

Candida Damian, Pediatrics/Psychiatry/Child Psychiatry Triple Board program at Brown University/Rhode Island Hospital

What are your thoughts on your match, and tell me about the programs you applied for?

I am very excited. There are only 11 Triple Board programs in the country, so I am super grateful to have matched. Since there are limited triple board positions, I applied for categorical psychiatry positions as well. I wanted to match into a Triple Board program because I am deeply passionate about the intersection of pediatrics and psychiatry, and am drawn to the diversity of experiences and the unique skill set that Triple Board training offers.

What do you know about the challenges of the specialty you’re entering, and how do you think you might be able to overcome them?

Entering a Triple Board program presents the challenge of navigating multiple specialties and wearing different hats, requiring adaptability and flexibility. I plan to overcome this by really leaning into my training and always asking for help.

There is a huge need, especially, for child psychiatrists. Mental health in children is a public health crisis. Entering a field with a high, under-met need is both daunting and inspiring. It underscores the urgency and importance of my chosen path. I see it as an opportunity to make a meaningful impact on individuals and communities who are underserved and often marginalized. By entering these fields, I aim to contribute to closing the gap in access to quality health care and improving outcomes for those in need.

What inspired you to go into medicine in the first place?

It has been my childhood dream to become a doctor. However, due to many external factors, I had believed a profession in medicine was just too far out of my reach. The idea of attending college was daunting enough, not to speak of attending medical school. I was committed to providing compassionate care for patients, so I channeled my energy into going to nursing school.

I will never forget the day as a third-year nursing student that I met a 16-year-old patient who confided in me about the events that led up to her being admitted into the psychiatric hospital. She had dreams of going to college and becoming a marine biologist. However, the external hardships she faced made her doubtful that she could accomplish her goals. She told me, “You know more about me than the doctors here do. I feel like I can tell you anything.”

We could relate to each other, we had similar upbringings, and I learned that just my presence alone was able to give patients that feeling of safety they often lacked. I recognized that all of the reasons that led me to believe I could not become a physician were actually the reasons why I needed to become a physician.

That patient’s story and trust in me during my nursing rotation helped me believe, for the first time, that becoming a physician was attainable. My determination to make a difference outweighed the fear. That day, I Googled “How to get into medical school” and the rest was history.

What impact do you hope to achieve in your specialty?

In my specialty, I hope to provide compassionate and comprehensive care to vulnerable populations, especially children and families who have endured significant abuse and neglect. My aim is to intervene promptly and treat both their physical and mental health needs at each developmental milestone, while fostering trust, empowerment, and providing a safe environment for healing and growth. I am dedicated to raising awareness about the impact of trauma and I am on a mission to help break down the many barriers faced so that future generations have the opportunity to pursue their dreams despite external challenges.

2024 Jacobi Medallion Award Ceremony

Seated, from left: Helen M. Fernandez, MD, MPH, MSH ’01; Marla C. Dubinsky, MD; Emma Guttman-Yassky, MD, PhD; Roxana Mehran, MD, MSH ’95; and Stephen Harvey, CPA, MBA. Standing, from left: Dennis Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai; Stuart A. Aaronson, MD; Peak Woo, MD; Mark Kostegan, FAHP; Kirk N. Campbell, MD; Sandra K. Masur, PhD, FASCB; Brendan G. Carr, MD, MA, MS, Chief Executive Officer of the Mount Sinai Health System; and Leo M. Keegan, MD, MSSM ’86, MSH ’94. Not pictured: Jeremy H. Boal, MD, MSH ’96

The Mount Sinai Alumni Association and Icahn School of Medicine at Mount Sinai presented accomplished physicians, researchers, educators, and administrators with the 2024 Jacobi Medallion, one of Mount Sinai’s highest awards. The annual ceremony was held Thursday, March 14, at the Plaza Hotel.

The recipients of the Jacobi Medallion have made exceptional contributions to the Mount Sinai Health System, Icahn Mount Sinai, the Mount Sinai Alumni Association, or the fields of medicine or biomedicine.

Watch the ceremony

View the digital program

Watch the In Memoriam video

Stuart A. Aaronson, MD

Founding Chair Emeritus, Department of Oncological Sciences

Jane B. and Jack R. Aron Professor of Neoplastic Diseases, Icahn School of Medicine at Mount Sinai

Associate Director for Basic and Translational Research, The Tisch Cancer Institute’s NCI-designated Cancer Center

Watch a video of Dr. Aaronson

Jeremy H. Boal, MD, MSH ’96

Executive Vice President and Chief Clinical Officer, Mount Sinai Health System, and President of Mount Sinai Beth Israel and Downtown until December 2023

Department of Population Health Science and Policy

Watch a video of Dr. Boal

Kirk N. Campbell, MD

Irene and Dr. Arthur M. Fishberg Professor of Medicine in the Division of Nephrology

Professor of Pharmacological Sciences

Founding Director of the Center for Kidney Disease Innovation

Icahn School of Medicine at Mount Sinai

Watch a video of Dr. Campbell

Marla C. Dubinsky, MD

Professor of Pediatrics and Medicine, Icahn School of Medicine at Mount Sinai

Chief of Pediatric Gastroenterology and Nutrition, Mount Sinai Kravis Children’s Hospital

Co-Director of the Susan and Leonard Feinstein IBD Clinical Center

Co-Director of the IBD Preconception and Pregnancy Planning Clinic at Mount Sinai

Watch a video of Dr. Dubinsky

Helen M. Fernandez, MD, MPH, MSH ’01

Vice Chair of Education, Brookdale Department of Geriatrics and Palliative Medicine

Icahn School of Medicine at Mount Sinai

Watch a video of Dr. Fernandez

Emma Guttman-Yassky, MD, PhD

Waldman Professor of Dermatology and Immunology

Health System Chair of the Department of Dermatology

Director, Center for Excellence in Eczema and the Laboratory for Inflammatory Skin Diseases

Icahn School of Medicine at Mount Sinai

Watch a video of Dr. Guttman-Yassky

Stephen Harvey, CPA, MBA

Chief Financial Officer, Mount Sinai Health System

Watch a video of Mr. Harvey

Mark Kostegan, FAHP

Chief Development Officer and Senior Vice President for Development at Mount Sinai

Watch a video of Mr. Kostegan

Roxana Mehran, MD, MSH ’95

Professor of Medicine

Director of Interventional Cardiovascular Research and Clinical Trials, Zena and Michael A. Wiener Cardiovascular Institute

Icahn School of Medicine at Mount Sinai

Watch a video of Dr. Mehran

Peak Woo, MD

Clinical Professor, Department of Otolaryngology and Head and Neck Surgery

Icahn School of Medicine at Mount Sinai

Watch a video of Dr. Woo

Mount Sinai’s Million Dollar Circle Recognition Honors Underrepresented Vendors

From left: Tiffany Oloke, Sourcing Lead II–Value Analysis; Patrice Gordon-Poyser, Supplier Diversity Manager; Carlos Maceda, Chief Supply Chain Officer; and Lynn Oxner, Director, Supply Chain, at the Million Dollar Circle Recognition event on February 9

Mount Sinai recently held its inaugural Million Dollar Circle Recognition event—celebrating 28 underrepresented vendors that each provided more than $1 million in products and services to the Health System in 2022 and 2023. More than $70 million was spent with the Million Dollar Circle vendors in each of those years.

“Supplier diversity is embedded in the culture, even the DNA of Mount Sinai,” Edward Robinson, Senior Vice President and Chief Resource Officer, Mount Sinai Health System, said at the event, which was held on February 9 at Mount Sinai’s Corporate Services Center. “This is our mission, to advance health equity and socioeconomics in the communities we serve.”

The event, attended by vendors and Mount Sinai staff and leadership, was moderated by Patrice Gordon-Poyser, Supplier Diversity Manager, Mount Sinai Health System. Leaders from three of the vendor honorees participated in the Million Dollar Journey panel. They discussed the services they provided to Mount Sinai, the effect of their long-standing business relationship on the growth of their companies, and ways in which they have been giving back to communities through charitable initiatives.

One of these vendors, a technology procurement fulfillment company that is Asian-American owned, was tasked with procuring iPads for patients, which allowed them to communicate with their loved ones while they were isolated during the COVID-19 pandemic.

“Getting there, not just from the technological perspective, but from one of procurement, putting it together, and delivering it, was one of the areas that I feel really stood out during our relationship with Mount Sinai,” said the vendor’s chief technology officer.

Another vendor on the panel, a veteran-owned staffing business, provided 50 crisis nurses for the Health System during the pandemic. “We all came together, Mount Sinai, our company, everybody here,” said the company’s chief executive officer. “It was an amazing New York moment, and something we are very proud of.”

The third vendor, a woman-owned office supply business, worked with Mount Sinai’s architectural design team to redesign Health System spaces that support employee well-being, including ergonomic chairs for nursing staff. As a health care provider, Mount Sinai posed unique challenges that helped the business evolve.

“Our client is not just Mount Sinai, our client is also the patient,” said the company’s director of marketing and workplaces strategy during the panel. “It really prompted us to develop a whole new health care department. Our staff all have more training and understanding in health care specifically.”

Carlos Maceda, Chief Supply Chain Officer, Mount Sinai Health System, commended the vendors for reaching the $1 million milestone. “I ask you to never forget where you came from, and to never forget your roots to be able to always help someone,” said Mr. Maceda.

Pamela Abner, Senior Vice President, Health Equity Officer, and Chief Diversity Operations Officer, Mount Sinai Health System, said that community vendors provide solutions through innovation and creativity in ways that would have been challenging for larger companies. She also noted how Mount Sinai’s relationship with local vendors helps New York City.

“By building community wealth, we build community health,” she explained.

To learn more about Mount Sinai’s commitment to supplier diversity, please visit Supplier Diversity or email supplierdiversity@mountsinai.org.

The Center for Advanced Medical Simulation at Mount Sinai West Hosts Annual Tristate Regional Simulation Symposium May 17

The Center for Advanced Medical Simulation (CAMS) at Mount Sinai West is hosting its pioneering annual Tristate Regional Simulation Symposium. The symposium is scheduled for Friday, May 17, from 11 am to 2 pm, using a live online format.

The theme for this eighth annual symposium is “Embracing Change: How Artificial Intelligence (AI) Can Influence Health Care Simulation.” The symposium will include plenary talks, data-driven presentations, and panel discussions.

“Together, we will explore AI possibilities to enhance patient safety, team performance, and outcomes in simulation-based education and powerfully affirm everything that is most striking about simulation that we do at our institutions and worldwide,” said Priscilla V. Loanzon, EdD, RN, CHSE, Director of Simulation Education, Center for Advanced Medical Simulation, and Assistant Professor of Medicine (Pulmonary, Critical Care, and Sleep Medicine) at the Icahn School of Medicine at Mount Sinai.

Since the pandemic, the format for the symposium has changed from a full-day onsite and in-person conference to a three-hour live online. The target audience has expanded over the years from regional to national and international. Attendees can earn credits for continuing medical education and continuing education units.

CAMS is one of the Mount Sinai Health System’s outstanding simulation centers, all dedicated to improving patient safety, communication, and medical education. It provides health care training opportunities to professionals in the safe learning environment of a lab setting, offering courses that include case-based simulation, in-situ simulation, and procedural training such as point of care ultrasonography, central line training, blood culture competency, medical code response, managing mechanically ventilated patients, and advanced airway management. The Center includes three simulation laboratories, a virtual-reality training arcade, and two conference rooms. All areas of CAMS are equipped with audiovisual and video-recording equipment to facilitate education, training, debriefing, and research and quality improvement projects.

The Center, accredited by the Society for Simulation in Healthcare (SSH), is working with the Continuing Medical Education Department, Mount Sinai’s Office of Corporate Compliance and Office of Development.

To learn more about the symposium, contact Dr. Loanzon at priscilla.loanzon@mountsinai.org or call 212-523-8698.

The Society for Simulation in Healthcare declared September 11-15, 2017, as an inaugural simulation week with a focus on celebrating the professionals who work in health care simulation to improve the safety, effectiveness, and efficiency of health care.

“CAMS invited the simulation centers in the tristate area to a joint celebration through a symposium,” said Dr. Loanzon. “This inaugural celebration was intended to powerfully affirm the tristate region’s successes, opportunities, and myriad possibilities to be the best in what we do so well individually and collectively.”

New Opera on a Gender-Affirmation Pioneer Is Authored by Mount Sinai Neuroradiologist

A new opera, Lili Elbe, tells the story of one of the earliest recipients of gender-affirming surgery in 1930. The opera is a collaboration of Grammy Award-winning composer Tobias Picker and Aryeh Lev Stollman, MD, a neuroradiologist at Mount Sinai, who wrote the story and lyrics. Photos: Edyta Dufaj

“It’s a love story,” says Aryeh Lev Stollman, MD, a neuroradiologist at Mount Sinai, and the librettist for a new opera, Lili Elbe, which tells the story of one of the earliest recipients of gender-affirming surgery, in 1930. The opera, commissioned by the Theater St. Gallen of Switzerland, was named “Best World Premiere of 2023” at the OPER! AWARDS ceremony on January 29 at the Dutch National Opera in Amsterdam.

Lili Elbe focuses on a successful Danish painter who was married to another painter, Gerda Wegener. Though their marriage was eventually annulled by the King of Denmark and Lili’s name and sex were legally changed, they remained in love with each other. Lili’s case drew international attention, and a semi-autographical account of her story was captured in a book, Man Into Woman: An Authentic Record of a Change of Sex. Another book, The Danish Girl, was loosely based on her story and has become an important text in LGBQT+ literature and the basis for a film.

“We based our story on historical sources,” emphasizes Dr. Stollman. “The Danish Girl was highly fictionalized. But Lili Elbe was quite famous in her day, so we relied on her own writings and news accounts from the time.”

The opera Lili Elbe, in addition to being acclaimed for its artistry, is a significant milestone. It stars Lucia Lucas, a baritone, in the first grand opera for and about a person with trans experience. The Grammy Award-winning composer Tobias Picker, who is married to Dr. Stollman, befriended Lucia when he cast her in Don Giovanni in a Tulsa Opera production—the first time a transgender singer had played the leading role in an American opera. Mr. Picker, Dr. Stollman, and Lucia wanted to collaborate on an original project, and the story of Lili Elbe was chosen.

Tobias Picker, left, and Aryeh Lev Stollman, MD, taking a bow after a performance of the new opera at the Theater Saint Gallen in Switzerland. “This resonates with our work as physicians, health care workers, and support staff, because behind our work is love for humanity,” says Dr. Stollman. “We serve people, no matter their physical appearance, their background, or gender identity. And we do it through all types of difficult times and situations.”

“Tobias asked me to write the libretto—or the story and lyrics,” Dr. Stollman says. “But I worked very closely with Lucia as the dramaturg, to gain the insight of her experience and authenticity.” This is the second time Mr. Picker and Dr. Stollman have collaborated. The first was the inspiring opera Awakenings, based on the story of Oliver Sacks, MD, and his efforts to treat patients with sleeping sickness. That opera opened in June 2022 at the Opera Theatre of Saint Louis.

“Like Awakenings, we wanted Lili Elbe to have a mythic undercurrent,” Dr. Stollman says. “In Awakenings, we used the story of Sleeping Beauty. In Lili Elbe, the myth of Orpheus leading his lover, Eurydice, out of the underworld is a motif that reoccurs. I believe that myths have a strong emotional truth. In the myth, Orpheus is saying, ‘Don’t look back, you cannot return to your old life, but you are coming into a new life.’ And our characters are always moving to the future, to a new life, a new realization. And that’s the mythological underpinning.”

Lili Elbe discovers her true nature as a woman when her wife, Gerda, asks her to stand in for a female model who was delayed for a painting session. Gerda is entranced with the beauty of her husband, then called Einar Wegener, and it is she who bestows the name Lili. And as Lili embraces her identity, she says, “When you paint me now, I feel I have always been her.” Lili becomes a muse to Gerda, whose paintings of Lili win acclaim. But Gerda wrestles with how much space to allow Lili in their marriage. At first, she insists that Lili transition back to Einar in the evening. But as Lili makes her true identity known among their circle of friends, Lili wants to experience all the feelings of womanhood, including marriage and motherhood. And even though their marriage is annulled and they become involved with other lovers, their love for each other endures.

Lili becomes engaged to Claude LeJeune, a young man whose passion is creating perfumes from flowers through a delicate process called enfleurage. The symbolism of the flowers living on becomes a motif as Lili dies as a result of complications of one of her surgeries. And the life and story of Lili Elbe still resonate today.

“The opera is more than about love with a transgender person,” Dr. Stollman says. “It’s about love and transcending difficulties. It’s about a tragic heroine’s journey that starts with self-knowledge. And it’s about loss, because Gerda loses Lili. But also because Lili dies in the end, as many tragic heroines do.”

The staging and choreography of the opera are innovative, witty, and symbolic. As Gerda exhibits her paintings of Lili, they are symbolized by actors suspended above the stage, swirling in evocative poses. The prominent German newspaper Die Welt gave it an enthusiastic review, calling it “emotionally gripping, a delicate work of musical theater that unfolds as an Art Nouveau arc, amidst a bright, symbolist stage.” A leading Austrian paper, the Voralberger Zeitung, called it “an emotionally charged masterpiece.”

Dr. Stollman related the theme of love transcending all to the mission of Mount Sinai, which was founded to care for underserved people and is home to the Center for Transgender Medicine and Surgery, a world leader in gender-affirming care. “This resonates with our work as physicians, health care workers, and support staff, because behind our work is love for humanity. We serve people, no matter their physical appearance, their background, or gender identity. And we do it through all types of difficult times and situations.”

Your Guide to Colorectal Cancer Awareness and Prevention

A colorectal cancer awareness event at The Mount Sinai Hospital. Click here to learn more about colorectal cancer and early screening with Mount Sinai’s CHOICE Program. To discuss your screening options or if you have a referral, call 212-824-7887.

Colorectal cancer is the second leading cause of cancer deaths in both men and women in the United States. Although this cancer is highly treatable and preventable, about 140,000 Americans are diagnosed and more than 50,000 people die each year, according to the Centers for Disease Control and Prevention (CDC). In 2021, the United States Preventative Task Force updated its guidelines and lowered the starting age of screening from 50 to 45.

More than 93 percent of colorectal cancer cases occur in people 45 years old or older. More than 75-90 percent of colorectal cancer cases can be avoided through early detection and removal of pre-cancerous polyps, and as many as 60 percent of colorectal cancer deaths could be prevented if men and women over the age of 45 were screened routinely.

In the United States, more than half (55 percent) of all cases of colorectal cancer are attributable to lifestyle factors, such as an unhealthy diet, insufficient physical activity, high alcohol consumption, and smoking. Increasing screening to 80 percent of people could reduce the number diagnosed with colorectal cancer by 22 percent by 2030. But survey data indicates that screening prevalence among adults remains low in those aged 45 to 54.

In an effort to increase awareness and screening, Mount Sinai has expanded colorectal cancer awareness initiatives across all eight hospital sites during March to provide patients with access to health professionals to discuss prevention, screening options, and risk factors. Mount Sinai experts will be available to answer questions on diet, genetic counseling, the colonoscopy procedure, and ways to schedule and offer support after diagnosis.

Here are some prevention tips:

Schedule a Screening

A colonoscopy is the preferred screening method as it allows for both detection and removal of precancerous polyps during the same procedure. Other screening options include a flexible sigmoidoscopy, CT colonography, and home-based stool tests, including the fecal occult blood test (FOBT), fecal immunochemical test (FIT), and a combined fecal immunochemical test with DNA test (FIT-DNA test). Individuals should discuss all of these options with their doctor to find which method works best for their lifestyle.

Know Your Risk Factors 

Age: More than 90 percent of colorectal cancer cases occur in people 45 years old or older and death rate increases with age. In New York, 44 percent of those 45 to 54 are up to date with colorectal screening.

Family history:  As many as 1 in 3 people who develop colorectal cancer have other family members who have been affected by this disease. The risk is even higher if a relative was diagnosed under age 50 or if more than one first-degree relative (parent, sibling, or child) has been affected.

Racial and ethnic background: Colorectal cancer affects people of all races and ethnicities. However, colorectal cancer disproportionately affects the Black community, where the rates are the highest of any racial/ethnic group in the United States. Black individuals are most likely to be diagnosed with late-stage colorectal cancer. The incidence of this cancer in Black individuals is 15 percent higher than in white individuals. Death rates have declined in Black individuals by 3 percent. Colorectal cancer screening rates are now lowest among Asian Americans and Hispanic/Latino communities.

Lifestyle factors: Common lifestyle factors that may increase colorectal cancer risk include obesity; cigarette smoking; lack of exercise; overconsumption of fat, red, and processed meats; not eating enough fiber, fruits, and vegetables; and drinking alcohol excessively.

Pre-existing health conditions: Inflammatory bowel diseases (IBD), such as ulcerative colitis or Crohn’s disease, and less common genetic syndromes, such as familial adenomatous polyposis (FAP) or Lynch syndrome, significantly increase the risk of developing colorectal cancer. These patients are recommended to start screening at a younger age and more frequently.

Warning Signs and Symptoms 

  • A change in bowel habits, such as diarrhea, constipation, or narrowing of the stool, lasting for more than a few days.
  • Rectal bleeding, dark stools, or blood in the stool.
  • Cramping or abdominal pain.
  • Weakness and fatigue.
  • Unintended weight loss.

Pin It on Pinterest